United Pharma Partners

United Pharma Partners Austria GmbH Announces Distribution Agreement with Insmed Netherlands B.V. for Brinsupri® and Arikayce® liposomal

SALZBURG, AUSTRIA — June 26, 2026

United Pharma Partners Austria GmbH (UPP), a distributor of specialized pharmaceutical products, announced today that it has entered into a distribution agreement with Insmed Netherlands B.V.

Under the terms of the agreement, UPP will assume exclusive distribution responsibilities for Brinsupri® 25 mg film-coated tablets in Austria. In addition, UPP will support the distribution of Brinsupri® and Arikayce® liposomal 590 mg nebulizer dispersion in selected countries of the European Economic Area (EEA) in accordance with applicable national regulations.

The agreement establishes the operational framework for distribution, logistics, and supply activities, leveraging UPP’s infrastructure and delivery in the relevant territories. Logistic and supply chain operations under this agreement have commenced.

About United Pharma Partners Austria GmbH

United Pharma Partners Austria GmbH is a specialized pharmaceutical distribution company focused on the management of complex supply chains for medicinal products. Its activities include the distribution of authorized medicines, as well as the coordination of Named Patient Supply and other regulated access pathways across Europe, in accordance with applicable legal and regulatory requirements.

Media & General Inquiries

For further information regarding this agreement or distribution operations, please contact:

Note:

  1. United Pharma Partners does not provide medical information. Requests of a medical or scientific nature will be directed to the relevant marketing authorization holder.

  2.  This communication is intended for media and business stakeholders only

  3. Brinsupri® and Arikayce® liposomal are registered trademarks of Insmed Incorporated (or its affiliates), used by United Pharma Partners Austria GmbH under license/with permission.